Aldeyra Therapeutics, Inc.【ALDX】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
2Q25 -469,808 +12.1%
1Q25 -460,041 +14.3%
4Q24 -450,111 +14.2%
3Q24 -434,302 +11.5%
2Q24 -419,189 +9.9%
1Q24 -402,342 +8.1%
4Q23 -394,260 +10.5%
3Q23 -389,507 +13.3%
2Q23 -381,320 +15.8%
1Q23 -372,333 +19.5%
4Q22 -356,717 +21.0%
3Q22 -343,815 +23.3%
2Q22 -329,262 +25.1%
1Q22 -311,481 +25.5%
4Q21 -294,693 +24.4%
3Q21 -278,938 +23.6%
2Q21 -263,143 +21.4%
1Q21 -248,206 +18.6%
4Q20 -236,916 +18.8%
3Q20 -225,624 +21.2%
2Q20 -216,751 +29.4%
1Q20 -209,231 +35.7%
4Q19 -199,362 +43.9%
3Q19 -186,202 +45.6%
2Q19 -167,487 +43.0%
1Q19 -154,160 +42.7%
4Q18 -138,536 +39.0%
3Q18 -127,902 +38.0%
2Q18 -117,090 +33.5%
1Q18 -108,039 +31.1%
4Q17 -99,642 +28.9%
3Q17 -92,688 +27.6%
2Q17 -87,702 +29.2%
1Q17 -82,393 +29.6%
4Q16 -77,302 +31.9%
3Q16 -72,650 +33.9%
2Q16 -67,872 +33.4%
1Q16 -63,570 +30.7%
4Q15 -58,602 +26.0%
3Q15 -54,247 +23.1%
2Q15 -50,881 +21.0%
1Q15 -48,649 -
4Q14 -46,512 -
3Q14 -44,067 -
2Q14 -42,058 -